Navigation Links
Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
Date:2/6/2008

SUNNYVALE, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) will announce financial results for the fourth quarter and full year 2007 after the markets close on Thursday, Feb. 28, 2008. The announcement will be followed by a live conference call and webcast that afternoon at 4:30 p.m. Eastern Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080129/LATU101LOGO)

John Bishop, Chief Executive Officer, and Michael Myhre, Vice President, Corporate Controller, will host the conference call to discuss Cepheid's financial results and business highlights. David Persing M.D., Ph.D., Executive Vice President and Chief Medical and Technology Officer, and Robert Koska, Senior Vice President Worldwide Commercial Operations, will also participate in the Q-and-A portion of the call.

Interested participants and investors may access the teleconference call by dialing 888-680-0860 (U.S./Canada) or 617-213-4852 (international), participant code 58037054. A telephonic replay will be available for seven days beginning at 6:30 p.m. Eastern Time. Access numbers for this replay are 888-286-8010 (U.S./Canada) and 617-801-6888 (international); participant code 29481680. Callers can also pre-register for the call through the following link: https://www.theconferencingservice.com/prereg/key.process?key=PUEA9KDFL

The webcast of the call can be accessed on the Investor section of Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download, and install any necessary software. After the live webcast, a replay will remain available in the Investors section of Cephe
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
2. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
3. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
4. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
5. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
6. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
7. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
8. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
9. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
10. WorldHeart Schedules Teleconference
11. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...swire-FirstCall/ -- Imaging Diagnostic,Systems, I...r optical breast,imaging, announced today that a ...t to mammography is featured in the December 2008 ...tp://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOG...at Charite Hospital in Berlin,Germany, authored ...
(Date:12/4/2008)...ll/ -- NeoStem, Inc.,(NYSE Alternext US: NBS), wh...cessing and long-term storage of adult stem cells ...has reached a major milestone in its current busin...ction center for collection of,adult stem cells b...w York,City and has chosen Bruce Yaffe, M.D., Yaf...
(Date:12/4/2008)...e/ -- MedImmune today announced that,it has initi...onic asthma to,determine the safety of subcutaneo...) that targets the interleukin-5 receptor (IL-5R)....5R pathway may lead to a targeted approach for,tr...study of this antibody. , "Asthma can be a ...
(Date:12/4/2008)...zur Pharma Limited ("Azur") today,announced that ...oSante,Pharmaceuticals, Inc ("BioSante")(Nasdaq: ...Elestrin is a fast drying gel formulation of estra...rate to severe vasomotor symptoms,associated with... and Drug,Administration ("FDA") in December 2006...
Breaking Biology Technology:Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2
..., , , , , , Multiporator / ..., , , , Transfo...15.540 07/2002 , , , , ,... , Microorganism , Pedioco... type , Bacteria, gram positive, ...
..., , , , , , Multiporator / ..., , , , Transfo...15.526 01/2002 , , , , ,... , Microorganism , Nocardi...ll type , Bacteria, gram positive, ...
..., , , , , , Multiporator / ..., , , , Transfo...15.525 01/2002 , , , , ,... , Microorganism , Nocardi...ell type , Bacteria, gram positive, ...
..., , , , , , Multiporator / ..., , , , Transfo...15.519 12/2001 , , , , ,... , Microorganism , Lactoco... Cell type , Bacteria, gram positiv...
Other Biology Technology:Pediococcus spp. 2Nocardia corallina 2Nocardia asteroides 2Lactococcus lactis 2
(Date:12/4/2008)... Wake Forest University,s School of Biomedical Eng...ics has received the Army Modeling and Simulation ...f of Staff of the Army and Director of the Army pr...ly help save eyesight and reduce morbidity and mor...ter was selected from 57 applicants from around th...
(Date:12/4/2008)...ant,s defences and causes disease,by sneakily di...,revealed in new research out today (4 December) ...on a pathogen which causes bacterial speck disease... black lesions on leaves,and fruit. Severe infect...to crops, and researchers believe that understandi...
(Date:12/4/2008)... with higher levels of omega-3 fatty acids in plas...of the European study IMMIDIET that will be publis...of Clinical Nutriti on, an official publication of... available on line ( www.ajcn.org ). The study su...drinks. This effect could be ascribed to compounds...
(Date:12/4/2008)...o monitor deforestation and degradation in tropica... and Betty Moore Foundation has awarded the Carneg... a $1.6-million grant to expand and improve CLASLi...new, user-friendly method that enables even the sm...ons (NGOs) to map tropical forests from their desk...
Breaking Biology News(10 mins):New dummy design and development wins US Department of Defense award 2Red alert! How disease disables tomato plant's 'intruder alarm' 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 2A little wine boosts omega-3 in the body: Researchers find a novel mechanism for a healthier heart 3Tropical forest carbon monitoring gets big boost 2Senator Dean Barkley Pledges Action on HIV AIDS Epidemic 28008 1Senator Dean Barkley Pledges Action on HIV AIDS Epidemic 28008 2Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 1Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 2Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 3Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 4Anadys Pharmaceuticals Commences Dosing ANA598 in Hepatitis C Patients in Phase Ib Study 28006 5Animal Health International Inc Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information 28004 1Elaborate Network Drives When and Where Proteins Are Made 28003 1Elaborate Network Drives When and Where Proteins Are Made 28003 2
...olecule and snake venom may provide researchers wi...ases and developing new drugs. , Purdue University...a dendrimer, with a glowing identification tag tha...om cells from a rattlesnake. The scientists want t...centration and function of proteins involved in di...
...ity of Wisconsin School of Medicine and Public Hea...try taking part in a novel clinical trial investig...rm of severe coronary artery disease. , The trial,...lling subjects in the Autologous Cellular Therapy .... The first patient underwent the procedure March ...
...1st issue of G&D, Drs. Yong Sun Lee and Anindy...s tumor suppressors in vitro. , "Overexpression o...important tumors like uterine fibroids,?explains D...roRNAs have an important role in suppressing the o...the causation and perhaps the cure of a disease th...
...mals, males advertise to potential mates with show... levels. However, a new study suggests that, in fi...rations to be more susceptible to pathogens. , In ... a new study by Judith Mank (Uppsala University, ...howy traits ?such as bright colors or long tails a...
Other Biology News:Scientists use nanoparticle to discover disease-causing proteins 2UW launches study testing adult stem cells for heart damage repair 2UW launches study testing adult stem cells for heart damage repair 3
Proteinase K Buffer 3.9 ml
RNase Buffer 25 ml
Mouse cAMP / Ca2+ Signaling PathwayFinder, PCR Array for expression profiling from SuperArray Bioscience
Silencer siRNA Starter Kit from Ambion
Biology Products: